Global Health Experts Hail PCOS Renaming as PMOS, Say Change Reflects Women’s Real Health Burden

By Iyojo Ameh

Global health and gender rights advocates have welcomed the renaming of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS), describing the move as a major breakthrough in women’s healthcare and a step toward addressing longstanding misconceptions about the condition.

The change, announced in May 2026 through a collaboration between the International PCOS Network and The Lancet, was highlighted during a global SHE & Rights forum held to commemorate the International Day of Action for Women’s Health and Menstrual Hygiene.

Health experts say the previous name, PCOS, focused primarily on ovarian cysts and failed to capture the full complexity of a condition that affects millions of women worldwide.

Speaking at the forum, SHE & Rights Campaign Coordinator, Shobha Shukla, said the new designation better reflects the hormonal, metabolic and reproductive dimensions of the disorder.

According to her, PMOS affects approximately one in eight women globally and is associated with insulin resistance, irregular menstrual cycles, fertility challenges, weight management difficulties and mental health concerns.

“The old name misrepresented the condition by suggesting it was merely about ovarian cysts, whereas it is a complex systemic disorder that affects multiple aspects of a woman’s health,” she said.

Programme Officer of the Women’s Global Network for Reproductive Rights, Joie Cortina, described the rebranding as a significant victory for women’s health advocacy and evidence-based medicine.

She noted that women’s health conditions have historically received limited attention in scientific research and healthcare policy, often resulting in delayed diagnosis, inadequate treatment and poor public awareness.

“The shift from PCOS to PMOS signals a more comprehensive understanding of the condition and validates the lived experiences of millions of women who have struggled with symptoms that extend far beyond reproductive health,” Cortina said.

Advocates believe the new terminology will strengthen awareness campaigns, improve medical education and encourage healthcare providers to adopt more holistic approaches to diagnosis and treatment.

The development is also seen as part of a broader effort to place women’s voices and experiences at the centre of health research, policy formulation and clinical practice.

Experts argue that accurate terminology is essential for improving patient outcomes, attracting research funding and ensuring that women receive appropriate care for conditions that have long been misunderstood or overlooked.

Why It Matters

The renaming of PCOS to PMOS goes beyond a change in terminology. Health advocates say it represents a shift toward recognizing the full scope of a condition that affects millions of women globally but is often underdiagnosed and poorly understood.

By highlighting the metabolic and hormonal dimensions of the disorder, the new name could lead to earlier diagnosis, better treatment strategies and increased awareness among healthcare providers and the public.

The move also reflects growing efforts within the global health community to address gender gaps in medical research and ensure that women’s health conditions are understood based on scientific evidence and lived experiences rather than outdated assumptions.